Uremic Solutes Database HOME   SOLUTE LIST   SOLUTE DETAILS   STATISTICS   LOGIN   REGISTER Solute Details for Parathyroid hormone Switch to solute: 1-Methyladenosine 1-Methylguanosine 1-Methylinosine 2-Heptenal 2-Hexenal 2-Nonenal 2-Octenal 3-Carboxy-4-Methyl-5-Propyl-2-Furanpropanoic Acid (CMPF) 3-Deoxyglucosone 4-Decenal 4-HO-Decenal 4-HO-Hexenal 4-HO-Nonenal 4-HO-Octenal 4-Pyridone-3-carboxamide-1-β-D-ribonucleoside 8-Hydroxy-2’-deoxyguanosine Adiponectin Adrenomedullin Angiogenin Arab(in)itol Argininic Acid Asymetric Dimethylarginine (ADMA) Atrial Natriuretic Peptide (ANP) Basic fibroblast growth factor (BFGF) Calcitonin gene-related peptide (CGRP) Cholecystokinin Clara cell protein (CC16) Complement Factor D Creatine Creatinine Cystatin C Cytidine Decanal Degranulation Inhibiting Protein I Delta-sleep Inducing Peptide Dihydroxyphenylalanine (PB-DOPA) Dimethylamine Dimethylglycine Endothelin Erythritol Ethylamine Fructoselysine Glyoxal Guanidine Guanidinosuccinic acid Guanylin Heptanal Hexanal Hippuric acid (total) Homocysteine Hyaluronic acid (Hyaluronan) Hypoxanthine Indican Indole-3-acetic acid (free) Indole-3-acetic acid (total) Indoxyl sulfate (free) Indoxyl sulfate (total) Indoxyl-β-D-glucoronide Inosine Insulin-like growth factor 1 (IGF-1) Interleukin-10 Interleukin-18 Interleukin-1β Interleukin-6 Kinurenine Kynurenic Acid Leptin Malondialdehyde (MDA) Mannitol Melatonin Methionine-Enkephalin Methylglyoxal Methylguanidine Monomethylamine Motiline Myoinositol N(6)-Carboxymethyllysine (CML) N-methyl-2-pyridone-5-carboxamide N-methyl-4-pyridone-3-carboxamide N2,N2-Dimethylguanosine N4-Acetylcytidine N6-Methyladenosine N6-Threonylcarbamoyladenosine Neopterin Neuropeptide Y Nicotinamide Nonanal Orotic Acid Orotidine Osteocalcin Oxalate p-Cresylsulfate (free) p-Cresylsulfate (total) Parathyroid hormone Pentosidine Phenol Phenylacetic acid Phenylacetylglutamine Pseudouridine Putrescine Quinolinic Acid Resistin Retinol Binding Protein (RBP) S-Adenosylhomocysteine Sorbitol Substance P Symetric Dimethylarginine (SDMA) Taurocyamine Threitol Trimethylamine Trimethylamine-N-oxide Tumor Necrosis Factor Alpha (TNF) Urea Uric Acid Uridine Uroguanylin Vascular endothelial growth factor (VEGF) Vasoactive intestinal peptide (VIP) Vasopressin (ADH) Xanthine Xanthosine α-keto-δ-Guanidinovaleric Acid α-N-Acetylarginine α1-Acid glycoprotein β-2-Microglobulin β-Endorphin β-Guanidinopropionic Acid β-Lipotropin γ-guanidinobutyric Acid λ-Ig Light Chain Base data Name Parathyroid hormone Molecular weight 9225 Group Peptide Class Middle molecule Added 16.09.2009 Reference Pubmed: 12675874 Submitted by Vanholder Reviewed by Abou Deif Normal concentrations (CN) Date Mean (+/-SD) (low Range - high Range) n Reference Submitted by Reviewed by Notes 12.09.1983 0.51 (+/-0.03) µg/L 30 Comparison between the plasma concent... Abou Deif Argiles Grand mean 0.51 (+/-0.03) µg/L 30 ANOVA Dispersion Uremic concentrations (CU) Date Mean (+/-SD) (low Range - high Range) n Reference Submitted by Reviewed by Notes 14.03.2000 1.20 (+/-0.60) µg/L 10 Effect of 22-oxacalcitriol on bone hi... Vanholder Abou Deif 02.07.2003 0.22 (+/-0.03) µg/L 74 Relationship between plasma level of ... Abou Deif Argiles 11.01.2004 0.33 (+/-0.37) µg/L 58 Close association between parathyroid... Abou Deif Argiles 08.06.2007 0.28 (+/-0.10) µg/L 14 Altered motor nerve excitability in e... Abou Deif Argiles 08.04.2008 0.41 (+/-0.42) µg/L 12 Hemodialysis acutely improves hepatic... Abou Deif Argiles 08.01.2011 0.23 (+/-0.18) µg/L 62 Long-term effects of high-efficiency ... Abou Deif Argiles Grand mean 0.31 (+/-0.26) (0.22-1.20) µg/L 230 ANOVA F(5,224) = 25.62, p=-0.00: Significant differences between group means. Dispersion L:0.22, M:0.31, H:1.20 : B - (Medium scatter: Considerable degree of uncertainty.) Relative increase (CU/CN) 0.60 times higher than the average normal concentration. Pathological associations Date Category Reference Comment 11.01.2004 Cardiovascular Close association between parathyroid... This study shows the role of excess PTH in the development of left ventricular hypertrophy as well as low LV ejection fraction. Notes No notes.